Powered by

-ORIC Pharmaceuticals to Present at Upcoming Investor Conference

Nov 20, 2018 - ENP Newswire

SOUTH SAN FRANCISCO - ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers, announced today that it will present at two upcoming investor conferences.

Chief Executive Officer Jacob Chacko will give a presentation about ORIC Pharmaceuticals and will host one-on-one investor meetings at both the Piper Jaffray 30th Annual Healthcare Conference and the Evercore ISI HealthCONx Conference.

The Pi...